MACC1 Hyperactivates Receptor Tyrosine Kinase Signaling Through Phosphorylation-Dependent Adaptor Activity in Colorectal Cancer Cells
Biomolecules · 2026
DOI: 10.3390/biom16091267 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Fabian Zincke und 8 weiteren Autor:innen. Beteiligte Einrichtung: Experimental and Clinical Research Center, Charité-Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Straße 1…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Trans-Activators, Receptor Protein-Tyrosine Kinases, Transcription Factors. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Consortium for Translational Cancer Research, German Cancer Consortium.
Abstract (Originalsprache)
Understanding the mechanisms of metastasis is one of the most pressing issues in cancer therapy. Metastasis-associated in colon cancer 1 (MACC1) is an important biomarker and functional driver of tumor progression and metastasis. However, the molecular mechanisms underlying its activity remain incompletely understood. Here, we demonstrate that MACC1 acts as an important adaptor protein that promotes hyperactivation of receptor tyrosine kinase (RTK) signaling pathways in colorectal cancer (CRC) cells. Based on mass spectrometry-based interactomics, we identified key MACC1 interactors, including GRB2, SHP2, SHC1, and STAT5B, that preferentially associate with tyrosine-phosphorylated residues Y365, Y379, and Y789. Site-directed mutagenesis of Y379 and Y789 reduced MACC1-induced migration, proliferation, and ERK phosphorylation. Using digital Western blotting (DigiWest), we observed a broad MACC1-dependent hyperactivation of downstream signaling effectors, including MEK, ERK, β-catenin, SRC, FAK, CREB, and VASP. Targeting MACC1-induced signaling with clinically relevant inhibitors effectively reversed MACC1-driven clonogenicity. Our findings support a role for MACC1 in promoting hyperactivation of RTK-associated signaling and reveal pharmacological vulnerabilities of potential relevance to metastasis-prone cancers characterized by elevated MACC1 expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Experimental and Clinical Research Center, Charité-Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Straße 10, 13125 Berlin, Germany.
- German Cancer Consortium (DKTK), Neuenheimer Feld 280, 69120 Heidelberg, Germany.
- Chair of Proteomics and Bioanalytics, Technical University Munich, Emil-Erlenmeyer-Forum 5, 85354 Freising, Germany.
- NMI TT GmbH, Markwiesenstraße 55, 72770 Reutlingen, Germany.
ORCID-Profile: Dennis Kobelt, Gerrit Erdmann, Mathias Dahlmann, Wolfgang Walther, Bernhard Küster, Ulrike Stein
Förderung
- German Consortium for Translational Cancer Research
- German Cancer Consortium
Zitieren
APA
Zincke, F., Kobelt, D., Kläger, S., Pachl, F., Erdmann, G., Dahlmann, M., Walther, W., Küster, B., & Stein, U. (2026). MACC1 Hyperactivates Receptor Tyrosine Kinase Signaling Through Phosphorylation-Dependent Adaptor Activity in Colorectal Cancer Cells. Biomolecules. https://doi.org/10.3390/biom16091267
Vancouver
Zincke F, Kobelt D, Kläger S, Pachl F, Erdmann G, Dahlmann M, et al. MACC1 Hyperactivates Receptor Tyrosine Kinase Signaling Through Phosphorylation-Dependent Adaptor Activity in Colorectal Cancer Cells. Biomolecules. 2026. doi:10.3390/biom16091267
BibTeX
@article{Zincke2026,
author = {Zincke, Fabian and Kobelt, Dennis and Kläger, Susan and Pachl, Fiona and Erdmann, Gerrit and Dahlmann, Mathias and Walther, Wolfgang and Küster, Bernhard and Stein, Ulrike},
title = {MACC1 Hyperactivates Receptor Tyrosine Kinase Signaling Through Phosphorylation-Dependent Adaptor Activity in Colorectal Cancer Cells},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16091267}
}
EUVIMED